Pfizer expands eligibility for RxPathways patient assistance programs

NEW YORK — Pfizer is looking to help more patients afford medication, announcing Thursday that it would be expanding eligibility for its RxPathways program, which offers services to help patients access medication. The change makes patients who earn up to four times the federal poverty level based on family size (up to $97,000 for a family of four) eligible for some of the 40 medicines offered for free by the program. 

 

“We have listened to patients and acted quickly to significantly expand the eligibility of our patient assistance programs. While patient assistance is not a permanent solution, it is a necessary step for helping to solve some of the high co-pay issues that some patients face,” Pfizer’s EVP corporate affairs Sally Susman said. “The real solution is to have a system that provides patients with access to innovative new treatments their doctors’ prescribe and insurance plans with good coverage.”

 

Programs provided through Pfizer RxPathways include 35%-50% discounts on retail price of the company’s medicine for uninsured patients, medicine access counseling to help choose assistance programs, insurance counseling to understand coverage, co-pay cards and information on other co-pay assistance programs and referrals to other resources. Between 2010 and 2015, the company has assisted 2.5 million patients with the program.